Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: A report from the Children's Cancer Group

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1190-1197

  Van Tornout, J M ^a   Buckley, J D ^a   Quinn, J J ^a   Feusner, J H ^a   Krailo, M D ^a   King, D R ^a   Hammond, G D ^a   Ortega, J A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEPATOBLASTOMA; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031050193     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1190     Document Type: Article

References (22)

1. Rouslathi E, Sepala M: Alpha-fetoprotein in cancer and fetal development. Adv Cancer Res 29:275-346, 1979
2. Gitlin D: Normal biology of alpha-fetoprotein. Ann NY Acad Sci 259:7, 1975 (abstr)
3. Wu JT, Book L, Sudan K: Serum alpha-fetoprotein (AFP) levels in normal infants. Pediatr Res 15:50, 1981 (abstr)
4. Tsuchida Y, Endo Y, Saito S, et al: Evaluation of alpha-fetoprotein in early infancy. J Pediatr Surg 13:155-156, 1978
5. Yachnin S: The clinical significance of human alpha-fetoprotein. Ann Clin Lab Sci 8:84-90, 1978
6. Mann JR, Lakin GE, Leonard JC, et al: Clinical applications of serum carcino-embryonic antigen and alpha-fetoprotein levels in children with solid tumors. Arch Dis Child 53:366-374, 1978
7. Ho DM, Liu HC: Primary intracranial germ cell tumor. Pathological study of 51 patients. Cancer 70:1577-1584, 1992
8. Ortega JA, Krailo MD, Haas JE, et al: Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous-infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group. J Clin Oncol 9:2167-2176, 1991
9. Walhof CM, Van Sonderen L, Voute PA, et al: Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma. Pediatr Hematol Oncol 5:217-227, 1988
10. Ortega JA, Siegel SE: Biological markers in pediatric solid tumors, in Pizzo AP, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 2). Philadelphia, PA, Lippincott, 1993, pp 179-194
11. Buamah PK, James OF, Skillen AW, et al: The value of tumor marker kinetics in the management of patients with primary hepatocellular carcinoma. J Surg Oncol 37:161-164, 1988
12. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
14. Buckley JD: Epilog User Manual. Pasadena, CA, Epicenter Software, 1994
15. Price JB, Schullinger JN, Santuli TV: Major hepatic resections for neoplasms in children. Arch Surg 117:1139-1142, 1982
16. Pritchard J, da Cunha A, Cornbleet NA, et al: Alpha fetoprotein monitoring of response to Adriamycin in hepatoblastoma. J Pediatr Surg 17:429-432, 1982
17. Quinn JJ, Altman AJ, Robinson HT, et al: Adriamycin and cisplatin for hepatoblastoma. Cancer 56:1926-1929, 1985
18. Ninane J, Perilongo G, Stalens JP, et al: Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A SIOP pilot study. Med Pediatr Oncol 19:199-203, 1991
19. Feusner J, Beach B, O'Leary M, et al: Pulmonary metastatic disease does not preclude survival in children with hepatoblastoma. Proc Am Soc Clin Oncol 5:212, 1986 (abstr)
20. Wanatabe I: Histopathological features of liver-cell carcinoma in infancy, in childhood and their relations to surgical prognosis. Jpn J Cancer Clin 23:691-698, 1977
21. Haas JE, Muczynski KA, Krailo M, et al: Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64:1082-1095, 1989
22. Nickerson HJ, Silberman TI, McDonald TP: Hepatoblastoma, thrombocytosis and increased thrombopoietin. Cancer 45:315-317, 1980